Victory Capital Management Inc Adverum Biotechnologies, Inc. Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023
SELL
$0.62 - $0.85 $57 - $79
-93 Reduced 0.91%
10,166 $7,000
Q4 2022

Feb 09, 2023
SELL
$0.54 - $10.3 $1 - $30
-3 Reduced 0.03%
10,259 $5,000
Q3 2022

Nov 02, 2022
SELL
$0.96 - $9.68 $406 - $4,094
-423 Reduced 3.96%
10,262 $10,000
Q2 2022

Aug 01, 2022
SELL
$0.81 - $1.34 $566 - $936
-699 Reduced 6.14%
10,685 $13,000
Q1 2022

May 04, 2022
SELL
$1.23 - $1.95 $399 - $633
-325 Reduced 2.78%
11,384 $12,000
Q4 2021

Feb 07, 2022
SELL
$1.74 - $2.4 $370 - $511
-213 Reduced 1.79%
11,709 $21,000
Q3 2021

Nov 02, 2021
SELL
$2.08 - $3.6 $1,202 - $2,080
-578 Reduced 4.62%
11,922 $26,000
Q2 2021

Aug 03, 2021
SELL
$3.36 - $10.56 $320,671 - $1.01 Million
-95,438 Reduced 88.42%
12,500 $44,000
Q1 2021

May 04, 2021
SELL
$9.26 - $14.36 $41,197 - $63,887
-4,449 Reduced 3.96%
107,938 $1.06 Million
Q4 2020

Feb 01, 2021
SELL
$9.84 - $14.26 $165,154 - $239,339
-16,784 Reduced 12.99%
112,387 $1.22 Million
Q3 2020

Nov 09, 2020
SELL
$10.3 - $21.64 $17,499 - $36,766
-1,699 Reduced 1.3%
129,171 $1.33 Million
Q2 2020

Aug 07, 2020
SELL
$8.53 - $25.64 $5.65 Million - $17 Million
-661,952 Reduced 83.49%
130,870 $2.73 Million
Q1 2020

May 04, 2020
SELL
$7.98 - $16.32 $223,878 - $457,857
-28,055 Reduced 3.42%
792,822 $7.75 Million
Q4 2019

Feb 06, 2020
BUY
$5.12 - $12.22 $29,148 - $69,568
5,693 Added 0.7%
820,877 $9.46 Million
Q4 2019

Feb 04, 2020
BUY
$5.12 - $12.22 $1.25 Million - $2.99 Million
244,589 Added 42.87%
815,184 $8.05 Million
Q3 2019

Nov 12, 2019
BUY
$5.24 - $15.89 $1.97 Million - $5.97 Million
375,695 Added 192.76%
570,595 $3.11 Million
Q2 2019

Aug 15, 2019
SELL
$5.1 - $11.89 $61,760 - $143,987
-12,110 Reduced 5.85%
194,900 $2.32 Million
Q1 2019

May 03, 2019
SELL
$3.03 - $6.02 $7,059 - $14,026
-2,330 Reduced 1.11%
207,010 $1.09 Million
Q4 2018

Feb 05, 2019
BUY
$2.87 - $5.92 $179,776 - $370,828
62,640 Added 42.7%
209,340 $659,000
Q3 2018

Nov 01, 2018
SELL
$4.5 - $7.6 $36,180 - $61,104
-8,040 Reduced 5.2%
146,700 $888,000
Q2 2018

Aug 02, 2018
SELL
$5.3 - $6.9 $46,852 - $60,996
-8,840 Reduced 5.4%
154,740 $820,000
Q1 2018

May 04, 2018
BUY
$3.65 - $7.95 $597,067 - $1.3 Million
163,580 New
163,580 $949,000

Others Institutions Holding ADVM

# of Institutions
3
Shares Held
524K
Call Options Held
0
Put Options Held
0
View Full List

About Adverum Biotechnologies, Inc.

ADVM Quotes by TradingView
  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $471M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email